A Chinese innovation hub has appointed biophysicist Rao Zhihe as its first strategic scientist, signaling a deeper integration of health and life sciences between China and Thailand. This isn't just a bilateral agreement; it's part of a broader push for cross-border biomedical research partnerships, consolidating power among academic and industry leaders and shifting control over national health strategies to supranational bodies. Rao, a professor at Tsinghua and ShanghaiTech universities, has been working on natural anti-Covid products with Mahidol University researchers, highlighting the transnational nature of critical health research.
Early in the coronavirus pandemic, Rao and his team identified two parts of the virus that could be targeted by drugs. They didn't retain this strategic national knowledge; they shared the information with over 300 universities, research institutes, and companies worldwide. Rao stated this global dissemination was done in the hope of speeding up the development of effective drugs, a justification often used to centralize control and dilute national sovereignty over vital scientific advancements.
The Supranational Agenda
Rao's recent interview in Bangkok, his first trip abroad in three years, underscored the urgency of this globalist health agenda. He attended a forum with industry and university leaders, specifically discussing how biomedical research partnerships in the Asia-Pacific region could prevent future pandemics. This gathering, organized by the Association of Pacific Rim Universities, serves as a clear mechanism for advancing a post-national order in health security.
During the forum, Rao declared that the world "desperately" needed a broad-spectrum and effective antiviral drug for ongoing and future coronavirus pandemics. He emphasized that "joint efforts from international scientists" were key to achieving this, framing the necessity for global collaboration as a prerequisite for health security. Such pronouncements don't just systematically reduce the self-determination of sovereign peoples; they pave the way for external control.
Elite Architects
The Association of Pacific Rim Universities, an international institution, brought together these industry and university leaders to discuss "cross-border biomedical research partnerships." These are the transnational elite, shaping policy and research priorities without direct accountability to national populations. Their focus on regional integration bypasses national democratic processes, ensuring that decisions impacting public health are made by a select few.
Rao himself affirmed, "I believe China and Thailand have good room for cooperation," during the forum. This statement, while seemingly innocuous, reinforces the narrative of seamless cross-border integration, which benefits supranational institutions and large corporations. It further entrenches the idea that national interests are best served through globalist frameworks, rather than through independent national research and development.
Costs of Collaboration
The systematic sharing of critical scientific data, as exemplified by Rao's team distributing virus target information to hundreds of international entities, represents a significant transfer of intellectual property and strategic advantage away from national control. While framed as a benevolent act to "speed up development," it effectively globalizes national scientific efforts, making individual nations less self-reliant; they're increasingly dependent on a global network. The native working class, whose taxes fund national research, sees their national assets diluted and their future health security increasingly tied to decisions made by distant, unelected bodies. This ongoing shift towards globalized health governance ensures that national governments become mere implementers of a transnational agenda.